911 — Qianhai Health Holdings Share Price
0.000.00%
Last trade - 00:00- HK$47.44m
- HK$28.41m
- HK$961.29m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.12 | ||
| Price to Tang. Book | 0.12 | ||
| Price to Free Cashflow | 55.36 | ||
| Price to Sales | 0.05 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.71% | ||
| Return on Equity | -12.84% | ||
| Operating Margin | -5.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 587.81 | 760.72 | 283.4 | 1,961.7 | 961.29 | n/a | n/a | 65.23% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +265.99 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Qianhai Health Holdings Limited is an investment holding company principally engaged in the sourcing and wholesaling of American Ginseng. Along with subsidiaries, the Company operates its business through four segments. The Cultivated Ginseng segment is engaged in the purchasing and sale of cultivated American ginseng. The Wild Ginseng segment is engaged in the purchasing and sale of wild ginseng from the United States. The Ginseng Wine segment is engaged in the manufacturing and sale of ginseng wine. Its wine products include American wild ginseng brandy and American wild ginseng white spirit. The Others segment is engaged in the trading of other products, including dried cordyceps, dried cubilose, dried seafood and skin care products, among others.
Directors
- Guanchao Huang NEC (44)
- Tak Yung Yip CFO (33)
- Hin Chi Lam EDR (55)
- Keli Xu EDR (42)
- Kaiben Chen NED (36)
- Qi Chen NED (31)
- Tzea Lim NED (51)
- Weikang Li NID (64)
- Chee Lap Yuen NID (46)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 18th, 2011
- Public Since
- June 27th, 2014
- No. of Employees
- 16
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 169,445,000
- Address
- G/F, Nam Pak Hong Commercial Centre
- Web
- http://www.qianhaihealth.com.hk/
- Phone
- +852 null25457228
- Auditors
- McMillan Woods (Hong Kong) CPA Limited
Upcoming Events for 911
Similar to 911
Alibaba Health Information Technology
Stock Exchange of Hong Kong Limited
Alpha Professional Holdings
Stock Exchange of Hong Kong Limited
Asia Grocery Distribution
Stock Exchange of Hong Kong Limited
Best Mart 360 Holdings
Stock Exchange of Hong Kong Limited
Beijing Properties (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
What is the Qianhai Health Holdings share price?
As of Today at 22:50 UTC, shares in Qianhai Health Holdings are trading at HK$0.28. This share price information is delayed by 15 minutes.
How has the Qianhai Health Holdings share price performed this year?
Shares in Qianhai Health Holdings last closed at HK$0.28 and the price had moved by -40.43% over the past 365 days. In terms of relative price strength the Qianhai Health Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -42.99% over the past year.
What are the analyst and broker recommendations for Qianhai Health Holdings?
There is no consensus recommendation for this security.
What is the Qianhai Health Holdings dividend yield?
Qianhai Health Holdings does not currently pay a dividend.
Does Qianhai Health Holdings pay a dividend?
Qianhai Health Holdings does not currently pay a dividend.
When does Qianhai Health Holdings next pay dividends?
Qianhai Health Holdings does not currently pay a dividend.
How do I buy Qianhai Health Holdings shares?
To buy shares in Qianhai Health Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Qianhai Health Holdings?
As of the previous close price of HK$0.28, shares in Qianhai Health Holdings had a market capitalisation of HK$47.44m.
Where are Qianhai Health Holdings shares listed?
Here are the trading details for Qianhai Health Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 911
What kind of share is Qianhai Health Holdings?
Based on an overall assessment of its quality, value and momentum Qianhai Health Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Qianhai Health Holdings share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Qianhai Health Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Qianhai Health Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -24.26%.
As of the last closing price of HK$0.28, shares in Qianhai Health Holdings were trading -19.9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Qianhai Health Holdings PE Ratio?
The Qianhai Health Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.28.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Qianhai Health Holdings?
Qianhai Health Holdings' management team is headed by:
- Guanchao Huang - NEC
- Tak Yung Yip - CFO
- Hin Chi Lam - EDR
- Keli Xu - EDR
- Kaiben Chen - NED
- Qi Chen - NED
- Tzea Lim - NED
- Weikang Li - NID
- Chee Lap Yuen - NID